Holen Sie sich die Stockscreener-App
351.32
0.47%
1.63
Handel nachbörslich:
351.88
0.56
+0.16%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$349.69
Offen:
$348.57
24-Stunden-Volumen:
3.17M
Relative Volume:
1.15
Marktkapitalisierung:
$189.18B
Einnahmen:
$35.89B
Nettoeinkommen (Verlust:
$7.01B
KGV:
27.16
EPS:
12.9352
Netto-Cashflow:
$11.54B
1W Leistung:
+6.14%
1M Leistung:
+5.52%
6M Leistung:
+14.59%
1J Leistung:
+24.16%
1-Tages-Spanne:
$346.93
$353.25
1-Wochen-Bereich:
$329.31
$353.25
52-Wochen-Spanne:
$261.43
$353.25
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
351.32 | 188.30B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,039.51 | 951.18B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
224.44 | 533.63B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
223.93 | 390.19B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
152.22 | 286.13B | 54.45B | 14.42B | 17.15B | 7.333 |
|
NVO
Novo Nordisk Adr
|
62.89 | 284.29B | 46.69B | 15.29B | 9.25B | 3.4329 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains - simplywall.st
Amgen R&D EVP James Bradner On Upcoming Readouts And Doing Deals Around New Capabilities - Citeline News & Insights
Amgen Advances Teprotumumab Program With Completed Phase 1 Study in Healthy Chinese Volunteers - TipRanks
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for - Finviz
Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR - GlobeNewswire Inc.
J. Safra Sarasin Holding AG Has $69.74 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) to Release Quarterly Earnings on Tuesday - MarketBeat
Bernstein Calls 2026 a “Waiting Year” for Amgen’s (AMGN) MariTide - Insider Monkey
UBS Raises Price Target for Amgen (AMGN) Following Recent Analys - GuruFocus
Mutual of America Capital Management LLC Sells 3,290 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen's (NASDAQ:AMGN) 11% CAGR outpaced the company's earnings growth over the same five-year period - Yahoo Finance
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks - Finviz
Intact Investment Management Inc. Cuts Stock Position in Amgen Inc. $AMGN - MarketBeat
Will 340B Lawsuit Over Drug Discounts Shift Amgen's (AMGN) Access Strategy And Investment Narrative? - simplywall.st
Whittier Trust Co. Acquires 39,111 Shares of Amgen Inc. $AMGN - MarketBeat
Sector Gamma AS Increases Position in Amgen Inc. $AMGN - MarketBeat
Investment House LLC Has $7.31 Million Stake in Amgen Inc. $AMGN - MarketBeat
Cullen Frost Bankers Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Commerzbank Aktiengesellschaft FI - MarketBeat
Amgen Inc. $AMGN Shares Sold by AMF Tjanstepension AB - MarketBeat
Amgen stock pulled back after a six-day run — here’s what investors watch next week - TechStock²
Amgen (AMGN) Downgraded Amid Competitive Pressures and Uncertain Future - GuruFocus
Y Intercept Hong Kong Ltd Grows Position in Amgen Inc. $AMGN - MarketBeat
Mn Services Vermogensbeheer B.V. Purchases 3,900 Shares of Amgen Inc. $AMGN - MarketBeat
Resona Asset Management Co. Ltd. Lowers Stake in Amgen Inc. $AMGN - MarketBeat
UniSuper Management Pty Ltd Acquires 6,911 Shares of Amgen Inc. $AMGN - MarketBeat
Teacher Retirement System of Texas Decreases Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Strs Ohio - MarketBeat
Peering Into Amgen Inc's Recent Short Interest - Sahm
Assessing Amgen (AMGN) Valuation After The New Sagebrush 340B Lawsuit - simplywall.st
Amgen (AMGN) Faces Downgrade Amidst Promising Pipeline - GuruFocus
Amgen snaps after six straight sessions of gains - MSN
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance
Lockheed Martin Investment Management Co. Makes New $2.62 Million Investment in Amgen Inc. $AMGN - MarketBeat
Analyst recommendations: Amgen, P&G, Spotify, Duolingo, Moderna… - marketscreener.com
Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy? - Yahoo Finance
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks - simplywall.st
Amgen (AMGN) expands obesity strategy with Ro collaboration on GLP-1 therapies - MSN
Amgen (NASDAQ:AMGN) Hits New 1-Year HighHere's Why - MarketBeat
Amgen: A Buy In 2026 On Exciting MariTide ObesityT2D Potential (NASDAQ:AMGN) - Seeking Alpha
Amgen stock hits 52-week high at $346.41 - Investing.com
Sagebrush sues Amgen over 340B program row - The Pharma Letter
Rakuten Investment Management Inc. Purchases Shares of 27,258 Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Downgraded by Bernstein on Market Challenges - GuruFocus
Ember LifeSciences Taps Former Amgen Exec as CFO - Contract Pharma
Amgen downgraded at Bernstein on 2026 outlook - MSN
Cell and Gene Therapy Market Innovations and Key Players: Amgen - openPR.com
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - The AI Journal
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies - Finviz
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.32%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):